© Copyright 2009 by the American Association for Clinical Chemistry Plasma Renin Activity by Liquid Chromatography– Tandem Mass Spectrometry (LC-MS/MS):

Slides:



Advertisements
Similar presentations
Genomes and Proteomes genome: complete set of genetic information in organism gene sequence contains recipe for making proteins (genotype) proteome: complete.
Advertisements

Protein Quantitation II: Multiple Reaction Monitoring
Improvements in Mass Spectrometry for Life Science Research – Does Agilent Have the Answer? Ashley Sage PhD.
Micromass Quattro Ultima triple quadrupole mass spectrometric detector HPLC system (LC) Electrospray ionisation source (-ve & +ve ion) Photodiode array.
Mass Spectrometry Kyle Chau and Andrew Gioe. Computation of Molecular Mass -Mass Spectrum is a plot of intensity as a function of mass- charge ratio,
Alternative Calibration Strategies for the Clinical Laboratory: Application to Nortriptyline Therapeutic Drug Monitoring M.T. Olson, A. Breaud, R. Harlan,
Gas chromatography–mass spectrometry (GC-MS) is an analytical method that combines the features of gas-liquid chromatographyand mass spectrometry to identify.
* CORRESPONDING AUTHOR Bioanalysis of Exenatide: Intact Versus Signature Peptide Approach to Reach Optimal Sensitivity in Large Molecule Quantification.
Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications.
Quantification of low-abundance proteins in complexes and in total cell lysates by mass spectrometry Bastienne Jaccard and Manfredo Quadroni Université.
Quantitative Protein Analysis of CYP450 Induction via LC-MRM Analysis.
Previous Lecture: Regression and Correlation
FIGURE 5. Plot of peptide charge state ratios. Quality Control Concept Figure 6 shows a concept for the implementation of quality control as system suitability.
Year 12 Chemistry.  An analytical technique is a method that is used to determine the presence and concentration of a chemical compound or chemical element.
Tryptic digestion Proteomics Workflow for Gel-based and LC-coupled Mass Spectrometry Protein or peptide pre-fractionation is a prerequisite for the reduction.
Chapter 8 – Mass Spectrometry. Mass Spectrometry The mass spectrometer can be used for: – Quantitative analysis – as a sophisticated and very sensitive.
Zlata D. Clarka, M. Laura Parnasb and Elizabeth L. Frankb
Advanced Electrophoresis Solutions Ltd
Circulating Fragments of N- Terminal Pro B-Type Natriuretic Peptide in Plasma of Heart Failure Patients J.Y.Y. Foo, Y. Wan, B.L. Schulz, K. Kostner, J.
Production of polypeptides, Da, and middle-down analysis by LC-MSMS Catherine Fenselau 1, Joseph Cannon 1, Nathan Edwards 2, Karen Lohnes 1,
Chapter 9 Mass Spectrometry (MS) -Microbial Functional Genomics 조광평 CBBL.
Quantitative PCR Analysis of DNA, RNAs, and Proteins in the Same Single Cell A. Ståhlberg, C. Thomsen, D. Ruff, and P. Åman December 2012
Quantitative Insulin Analysis Using Liquid Chromatography–Tandem Mass Spectrometry in a High- Throughput Clinical Laboratory Z. Chen, M.P. Caulfield, M.J.
Acknowledgements This work is supported by NSF award DBI , and National Center for Glycomics and Glycoproteomics, funded by NIH/NCRR grant 5P41RR
Common parameters At the beginning one need to set up the parameters.
© Copyright 2009 by the American Association for Clinical Chemistry Quantification of Galactose-1-Phosphate Uridyltransferase Enzyme Activity by Liquid.
Integrated Targeted Quantitative Method for Insulin and its Therapeutic Analogs Eric Niederkofler 1, Dobrin Nedelkov 1, Urban Kiernan 1, David Phillips.
A Phospho-Peptide Spectrum Library for Improved Targeted Assays Barbara Frewen 1, Scott Peterman 1, John Sinclair 2, Claus Jorgensen 2, Amol Prakash 1,
Mass spectroscopy – learning objectives Outline the early developments in mass spectrometry. Outline the use of mass spectrometry in the determination.
INF380 - Proteomics-101 INF380 – Proteomics Chapter 10 – Spectral Comparison Spectral comparison means that an experimental spectrum is compared to theoretical.
OPTIMIZATION OF BISPHENOL A, 4-t-OCTYLPHENOL, AND 4-NONYLPHENOL EXTRACTION FROM HUMAN BLOOD SERUM WITH HYBRID SOLID PHASE EXTRACTION – PROTEIN PRECIPITATION.
Overview of Mass Spectrometry
Stability Indicating Assays for Dose Formulation Stability Testing Teresa Fuller GSK.
Isotope Labeled Internal Standards in Skyline
Mass Spectrometry Quantitative Mass Spectrometry
PERFLUORINATED CARBOXYLIC ACIDS AND SULFONIC ACIDS IN WASTE SAMPLES Katsuya Y 1 *,Takemine S 1, Matsumura C 1, Tsurukawa M 1, Haga Y 1, Fujimori K 1, Nakano.
Deducing protein composition from complex protein preparations by MALDI without peptide separation.. TP #419 Kenneth C. Parker SimulTof Corporation, Sudbury,
Toxicological Screening of 80 Drugs in Urine Using the High Resolution Exactive LC/MS Orbitrap Mass Spectrometer Coupled to Online Extraction and Turbulent.
What is proteomics? Richard Mbasu and Ben Richards.
Objective  To develop methods for analysis of compounds in organic aerosol particles Why is this important?  Environmental impact  Alternative fuels.
Introduction to Liquid Phase Mass Spectrometry
김지형. Introduction precursor peptides are dynamically selected for fragmentation with exclusion to prevent repetitive acquisition of MS/MS spectra.
3M Drug Delivery Systems 3 Introduction A family of hydrofluoroalkane-compatible excipients based on oligomeric lactic acid (OLA) has been proposed for.
Quantitation using Pseudo-Isobaric Tags (QuPIT) and Quantitation using Pseudo-isobaric Amino acids in Cell culture (QuPAC) Parimal Samir Andrew J. Link.
Data independent acquisition methods for metabolomics Stephen Tate, Ron Bonner AB SCIEX, 71 Four Valley Drive, Concord, ON, L4K 4V8 Canada A high resolution.
Target Analyses in Parallel Reaction Monitoring Mode (PRM)
Introduction The pyrolysis products of natural polymers often exhibit very similar neural losses during collision induced dissociation (CID) Some ions.
이 장 우. 1. Introduction  HPLC-MS/MS methodology achieved its preferred status -Highly selective and effectively eliminated interference -Without.
H M Arif Ullah, Hye Jin Chung*
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease  Hlin Kvartsberg, Flora.
LC-MS/MS Identification of Impurities Present in Synthetic Peptide Drugs Dr Anna Meljon*, Dr Alan Thompson, Dr Osama Chahrour, and Dr John Malone Almac.
A sensitive and repeatable method for characterization of sulfonamides and trimethoprim in honey using QuEChERS extracts with Liquid-Chromatography-Tandem.
C. Costa, R. Webb, V. Palitsin, M. Ismail, M. de Puit, S. Atkinson, M
by John M. Hamlyn, and Mordecai P. Blaustein
Protein/Peptide Quantification
AssayMAP Bravo for Automated Sample Preparation
Bioinformatics Solutions Inc.
Volume 65, Issue 2, Pages (January 2017)
Now, More Than Ever, Proteomics Needs Better Chromatography
Proteomic Approaches to Cancer Biomarkers
Interpretation of Mass Spectra I
A perspective on proteomics in cell biology
Volume 7, Issue 2, Pages (August 1997)
Nat. Rev. Nephrol. doi: /nrneph
Volume 7, Issue 2, Pages (August 1997)
Johnson Cheung, Michael E.P. Murphy, David E. Heinrichs 
Shotgun Proteomics in Neuroscience
Semisynthetic Src SH2 Domains Demonstrate Altered Phosphopeptide Specificity Induced by Incorporation of Unnatural Lysine Derivatives  Satpal Virdee,
Volume 11, Issue 4, Pages (April 2004)
Mass spectrometry (MS) is an analytical technique that can be used to determine the mass, elemental composition or chemical structure of molecules. Mass.
Presentation transcript:

© Copyright 2009 by the American Association for Clinical Chemistry Plasma Renin Activity by Liquid Chromatography– Tandem Mass Spectrometry (LC-MS/MS): Development of a Prototypical Clinical Assay Reveals a Subpopulation of Human Plasma Samples with Substantial Peptidase Activity C.E. Bystrom, W. Salameh, R. Reitz, and N.J. Clarke October © Copyright 2010 by the American Association for Clinical Chemistry Journal Club

© Copyright 2009 by the American Association for Clinical Chemistry Introduction  Plasma renin activity (PRA) is useful in diagnosis of secondary hypertension Traditionally determined via measurement of angiotensin (Ang) I using a broadly accepted RIA Accurate measurement of low activity is essential for diagnostic utility Narrow dynamic range of RIA is overcome via extended incubation of patient samples with low activity. Low activity samples are incubated for 18 h rather than 3 h

© Copyright 2009 by the American Association for Clinical Chemistry 0.65 µg/L/h 14 µg/L/h 25–35% 5% Samples above 14 µg/L/h are diluted or re-assayed with a short incubation before reporting Samples in this region are incubated for 3 hr and reported Samples below 0.65 µg/L/h are re-assayed with an 18 h incubation 30–40% of all patient samples require additional work beyond the first analysis RIA Workflow

© Copyright 2009 by the American Association for Clinical Chemistry Introduction (cont)  Ang I can be measured using mass spectrometry Extended incubation is not required due to the high sensitivity and wide dynamic range of the mass spectrometer Benefits in sample preparation improve throughput Improvements in precision may improve diagnostic utility

© Copyright 2009 by the American Association for Clinical Chemistry Wide Dynamic Range of Mass Spectrometry Wide Dynamic Range of Mass Spectrometry 5% of samples >14 µg/L/hr <0.65 µg/L/hr All samples can be determined in a single analysis

© Copyright 2009 by the American Association for Clinical Chemistry Introduction (cont)  A method for determination of PRA by mass spectrometry was validated Discordant results between 3 h LC-MS/MS and 18 h RIA results were observed with low frequency and suggested strong degradation activity Use of multiple, isotope labeled internal standards was used to identify samples with strong propensity for Ang I degradation. Mass spectrometry was used to characterize degradation products

© Copyright 2009 by the American Association for Clinical Chemistry  Why is Ang I degradation difficult to assess by RIA alone? Question

© Copyright 2009 by the American Association for Clinical Chemistry Materials and Methods  Thermo Quantum Ultra triple quadrupole  Cohesive automated HPLC system  Waters HLB online extraction cartridges  Waters X-bridge C18 analytical columns  De-identified residual clinical samples  Freshly collected non-hypertensive control samples  Heavy isotope labeled peptides

© Copyright 2009 by the American Association for Clinical Chemistry Materials and Methods (cont)  Synthetic, isotope labeled peptides for assay Ang I DRVYIHPFHL Da ISDRV*YIHPFHL Da DSDRV*YI*HPFHL Da  Isotope labeled peptides for characterization ProlineDRVYIHP*FHL Da HistidineDRVYIH*PGH*L Da Peptides are labeled with 15N and/or 13C enriched amino acids

© Copyright 2009 by the American Association for Clinical Chemistry Question  What are the advantages of using isotope- labeled peptides in these types of experiments?

© Copyright 2009 by the American Association for Clinical Chemistry Experimental Workflow for Monitoring Degradation 3h generation Ang I accumulation from renin activity DS elimination due to degradation if present Stop reaction with formic acid and add IS Patient sample buffer Ang I DS IS Patient sample buffer DS Analysis Determination of Ang I, DS, and IS by LC-MS/MS

© Copyright 2009 by the American Association for Clinical Chemistry Figure 1. Most samples show mild degradation of DS during extended incubation. Method comparison between RIA and LC-MS/MS. All samples for LC-MS/MS were generated for 3 h. For RIA data, samples with PRA 0.65 g/L/h were generated for 18 h; samples with PRA 0.65 g/L/h were generated for 3 h. For samples with PRA 14.9 g/L/h, the 3 h generated sample was diluted 1:5. The unity line is indicated as a solid line and the Deming regression as a dashed line. Residuals are plotted on the inset.

© Copyright 2009 by the American Association for Clinical Chemistry Very low DS recovery is associated with low PRA results Some Samples Show Dramatic Loss of DS

© Copyright 2009 by the American Association for Clinical Chemistry Degrading samples give rise to Ang I fragments. Figure 4. Degrading samples give rise to Ang I fragments. Contour ion maps of precursor ion scan data without background subtraction. The figure shows precursors of histidine immonium ion (m/z 113.1) and the Q1 scan from m/z 300–600. (A), Nondegrading human plasma at t 0 min. (B), Nondegrading human plasma sample at t 30 min. (C), Degrading human plasma sample at t 30. The 3 charge state of the spiked, isotope-labeled peptide (m/z 435) is circled in (A), (B), and (C). Newly appearing peaks as a result of degradation are indicated with boxes in (C).

© Copyright 2009 by the American Association for Clinical Chemistry Figure 5. Ang I degradation products can be characterized. Precursor scan ion total ion current (background subtracted) and representative precursor scan spectrum for major peak. Two coeluting degradation products with masses that match the experimental data are indicated with 2 and 3 charge states highlighted.

© Copyright 2009 by the American Association for Clinical Chemistry Conclusions  Profound degradation of Ang I is observed in some patient samples  Degradation of Ang I may be a confounding factor in the interpretation of some PRA results  Use of multiple isotope-labeled peptides may be employed to monitor degradation concomitant with Ang I generation

© Copyright 2009 by the American Association for Clinical Chemistry Questions  What results would you expect if direct renin measurements were made in degrading samples?